CDC25A-SLC26A6 Fusion FISH Probe
The CDC25A-SLC26A6 Fusion FISH Probe is used to confirm a fusion of the CDC25A and SLC26A6 genes. The fusion of the CDC25A and SLC26A6 genes has been associated with Uterine Corpus Endometrial Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| CDC25A-SLC26A6-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| CDC25A-SLC26A6-20-RERE | 20 (40 μL) | 200 μL |
|
|
| CDC25A-SLC26A6-20-REOR | 20 (40 μL) | 200 μL |
|
|
| CDC25A-SLC26A6-20-REGO | 20 (40 μL) | 200 μL |
|
|
| CDC25A-SLC26A6-20-REGR | 20 (40 μL) | 200 μL |
|
|
| CDC25A-SLC26A6-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| CDC25A-SLC26A6-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| CDC25A-SLC26A6-20-OROR | 20 (40 μL) | 200 μL |
|
|
| CDC25A-SLC26A6-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| CDC25A-SLC26A6-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| CDC25A-SLC26A6-20-GORE | 20 (40 μL) | 200 μL |
|
|
| CDC25A-SLC26A6-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| CDC25A-SLC26A6-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| CDC25A-SLC26A6-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| CDC25A-SLC26A6-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| CDC25A-SLC26A6-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| CDC25A-SLC26A6-20-GROR | 20 (40 μL) | 200 μL |
|
|
| CDC25A-SLC26A6-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| CDC25A-SLC26A6-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| CDC25A-SLC26A6-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| CDC25A-SLC26A6-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| CDC25A-SLC26A6-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| CDC25A-SLC26A6-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| CDC25A-SLC26A6-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| CDC25A-SLC26A6-20-AQAQ | 20 (40 μL) | 200 μL |
|
CDC25A Gene Summary
CDC25A is a member of the CDC25 family of phosphatases. CDC25A is required for progression from G1 to the S phase of the cell cycle. It activates the cyclin-dependent kinase CDC2 by removing two phosphate groups. CDC25A is specifically degraded in response to DNA damage, which prevents cells with chromosomal abnormalities from progressing through cell division. CDC25A is an oncogene, although its exact role in oncogenesis has not been demonstrated. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Gene Name: Cell Division Cycle 25A
Chromosome: CHR3: 48198667 -48229801
Locus: 3p21.31
SLC26A6 Gene Summary
This gene belongs to the solute carrier 26 family, whose members encode anion transporter proteins. This particular family member encodes a protein involved in transporting chloride, oxalate, sulfate and bicarbonate. Alternatively spliced transcript variants encoding distinct isoforms have been described. [provided by RefSeq, Aug 2013]
Gene Name: Solute Carrier Family 26 Member 6
Chromosome: CHR3: 48663155 -48672926
Locus: 3p21.31
Gene Diseases
The CDC25A SLC26A6 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Uterine Corpus Endometrial Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|